Description
Safrax Ingredient: Ursodeoxycholic Acid
Ursodeoxycholic Acid: At the heart of Safrax lies Ursodeoxycholic Acid, a naturally occurring bile acid found in small quantities in human bile. Each capsule encapsulates the therapeutic potential of 250 mg of Ursodeoxycholic Acid. This pivotal component serves as a multifaceted agent, recognized for its ability to dissolve certain gallstones and inhibit their formation. Additionally, Ursodeoxycholic Acid extends its healing touch to combat primary biliary cirrhosis, a liver disease characterized by damage to the bile ducts.
Auxiliaries
In concert with the active ingredient, Safrax capsules incorporate an ensemble of auxiliary substances, each with a defined role:
Pre-gelatinized Starch: This soluble starch variant, derived from a process of cooking and subsequent drying, finds its place as an auxiliary substance in Safrax. Its versatility is harnessed as a thickening agent, not only in pharmaceutical formulations but also in diverse food products.
Colloidal Silicon Dioxide: Also recognized as colloidal silica, this substance assumes its role as an auxiliary in Safrax. It is prepared through the hydrolysis of a silica compound and is commonly employed as a filler in various food and pharmaceutical products.
Magnesium Stearate: The unassuming yet crucial magnesium stearate, characterized by its fine white powder form, bestows lubricating properties to medications, vitamins, and even cosmetics. It is a salt formed by the union of stearic acid, a saturated fat, and the mineral magnesium.
Gelatin: Derived from collagen sourced from animal body parts, gelatin is a versatile ingredient. Its applications span the realms of capsules, cosmetics, ointments, and foods. In the context of Safrax, it finds its place as a capsule component.
Applications
Safrax casts a wide therapeutic net, addressing an array of conditions:
- Dissolution of Cholesterol Gallstones: Safrax proves efficacious in patients with functioning gallbladders, where cholesterol gallstones are of diminutive dimensions (less than 15 mm) and radiolucent (invisible on X-ray).
- Treatment of Primary Biliary Cirrhosis (PBC): In cases where decompensated liver cirrhosis is not present, Safrax offers respite to those battling PBC, a disease affecting the bile ducts and culminating in liver cirrhosis.
- Preventive Treatment for Gallstones/Cholestasis: Safrax serves as a preventive measure against gallstones and cholestasis, a condition characterized by the slowdown or cessation of bile flow, particularly in liver transplant patients.
- Intrahepatic Cholestasis of Pregnancy: A condition manifesting during the latter half of pregnancy and marked by widespread itching, intrahepatic cholestasis of pregnancy finds a potential remedy in Safrax.
- Hepatobiliary Diseases in Cystic Fibrosis: Safrax extends its therapeutic scope to hepatobiliary ailments associated with cystic fibrosis, a hereditary affliction causing damage to the lungs, kidneys, or pancreas.
Usage and Packaging
Safrax capsules are designed for oral administration, adhering to the prescribed dosage and guidance imparted by healthcare professionals. They are encapsulated in opaque white form, containing granules of the same hue. The capsules are presented in PVC/Aluminum blisters, with each blister housing 100 capsules.
Prudent Precautions
While Safrax emerges as a beacon of hope for various conditions, certain precautions merit consideration. Individuals with allergies to bile acids or any components within it should abstain from its use. Furthermore, acute inflammation in the gallbladder or bile ducts serves as a contraindication for it. Consultation with a healthcare professional remains pivotal in determining the appropriateness of it in individual health contexts.
Conclusion
In the realm of pharmaceutical solutions, Safrax stands as a testament to meticulous formulation and therapeutic versatility. It offers a lifeline to individuals grappling with diverse digestive and metabolic challenges. However, the guidance of healthcare professionals is indispensable to navigate its usage safely and effectively. It exemplifies the fusion of science and compassion, paving the way toward enhanced well-being.
Overview
| Component | Role |
|---|---|
| Active Ingredient | Ursodeoxycholic Acid, a bile acid with gallstone-dissolving and liver disease-fighting properties |
| Auxiliary Ingredients | Pre-gelatinized Starch, Colloidal Silicon Dioxide, Magnesium Stearate, Gelatin |
| Therapeutic Applications | Dissolution of Cholesterol Gallstones, PBC Treatment, Preventive Measures, and more |
| Usage | Oral administration as directed by healthcare professionals |
| Packaging | Opaque white capsules containing 250 mg of Ursodeoxycholic Acid, presented in PVC/Aluminum blisters (100 capsules) |
| Precautions | Allergies to bile acids or components, acute gallbladder or bile duct inflammation |
Note: This information serves as a reference and should not replace professional medical advice. Always consult healthcare professionals for personalized guidance on medication usage
Reviews
There are no reviews yet.